Protagenic Therapeutics Inc (NASDAQ:PTIX) does about 314.66K shares in volume on a normal day but saw 2045037 shares change hands in the recent trading day. The company now has a market cap of 4.96M USD. Its current market price is $0.73, marking an increase of 13.00% compared to the previous close of $0.65. The 52 week high reached by this stock is $1.87 whilst the lowest price level in 52 weeks is $0.49.
Protagenic Therapeutics Inc (PTIX) has a 20-day trading average at $0.6452 and the current price is -60.96% off the 52-week high compared with 48.98% distance from its 52-week low. The 50-day simple moving average of the closing price is $0.6162 and its 200-day simple moving average is $0.9522. If we look at the stock’s price movements over the week, volatility stands at 18.02%, which increases to 22.48% over 1 month. It is also key to look at other market indicators of price movement for the stock, where we see that the relative strength index (RSI) is at 58.14 to suggest the stock is neutral.
The consensus objective for the share price is $16.00, suggesting that the stock has a potential upside of 95.44% over the period.
The current price level is 13.15%, 18.46%, and -23.33% away from its SMA20, SMA50, and SMA200 respectively, with the PTIX price moving below the 50-day SMA on current market day. Protagenic Therapeutics Inc (PTIX) stock is up 25.67% over the week and 30.33% over the past month. Its price is -26.26% year-to-date and -14.62% over the past year.
The company’s next earnings report forecasts estimating quarterly EPS at 0 and 0 for whole year.
To reach the target analysts have set, the stock logically needs to grow 95.44 percent from here.
Outstanding shares total 6.79M with insiders holding 14.25% of the shares and institutional holders owning 5.77% of the company’s common stock. The company has a return on investment of -785.50% and return on equity of -231.87%. Price to book ratio is 4.88.
